Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Citi
UBS
Harvard Business School
Julphar
US Army
Merck
Mallinckrodt
Baxter
Express Scripts

Generated: October 23, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021168

« Back to Dashboard
NDA 021168 describes DEPAKOTE ER, which is a drug marketed by Abbvie and is included in one NDA. It is available from ten suppliers. There are six patents protecting this drug and two Paragraph IV challenges. Additional details are available on the DEPAKOTE ER profile page.

The generic ingredient in DEPAKOTE ER is divalproex sodium. There are seventeen drug master file entries for this compound. Fifty-two suppliers are listed for this compound. Additional details are available on the divalproex sodium profile page.

Summary for NDA: 021168

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:6
Therapeutic Class:Anticonvulsants
Antimigraine Agents
Bipolar Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 021168

Suppliers and Packaging for NDA: 021168

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DEPAKOTE ER
divalproex sodium
TABLET, EXTENDED RELEASE;ORAL 021168 NDA AbbVie Inc. 0074-3826 0074-3826-11 10 BLISTER PACK in 1 CARTON (0074-3826-11) > 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
DEPAKOTE ER
divalproex sodium
TABLET, EXTENDED RELEASE;ORAL 021168 NDA AbbVie Inc. 0074-3826 0074-3826-13 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0074-3826-13)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET, EXTENDED RELEASE;ORALStrengthEQ 500MG VALPROIC ACID
Approval Date:Aug 4, 2000TE:ABRLD:Yes
Patent:► SubscribePatent Expiration:Jun 18, 2019Product Flag?Substance Flag?Delist Request?Y
Patent:► SubscribePatent Expiration:Jun 18, 2019Product Flag?Substance Flag?Delist Request?Y
Patent:► SubscribePatent Expiration:Jun 18, 2019Product Flag?Substance Flag?Delist Request?Y

Expired Orange Book Patents for NDA: 021168

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbvie
DEPAKOTE ER
divalproex sodium
TABLET, EXTENDED RELEASE;ORAL021168-002May 31, 2002► Subscribe► Subscribe
Abbvie
DEPAKOTE ER
divalproex sodium
TABLET, EXTENDED RELEASE;ORAL021168-001Aug 4, 2000► Subscribe► Subscribe
Abbvie
DEPAKOTE ER
divalproex sodium
TABLET, EXTENDED RELEASE;ORAL021168-001Aug 4, 2000► Subscribe► Subscribe
Abbvie
DEPAKOTE ER
divalproex sodium
TABLET, EXTENDED RELEASE;ORAL021168-001Aug 4, 2000► Subscribe► Subscribe
Abbvie
DEPAKOTE ER
divalproex sodium
TABLET, EXTENDED RELEASE;ORAL021168-002May 31, 2002► Subscribe► Subscribe
Abbvie
DEPAKOTE ER
divalproex sodium
TABLET, EXTENDED RELEASE;ORAL021168-002May 31, 2002► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Cipla
Mallinckrodt
Moodys
Express Scripts
Queensland Health
Harvard Business School
Boehringer Ingelheim
Dow
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot